Aducanumab FDA Approval for Alzheimer's Disease: The Importance of G…

Anton Porsteinsson

Differentiating Early Signs of Alzheimer Disease From Normal Signs o…

ACHL

J. Galvin

Myths and Misconceptions About Parkinson Disease: What Is a Role of …

Mayo Clinic Proceedings

E. Ahlskog

Not Your Grandmother's Dopamine: Pairing Clinical Studies With Dopam…

PMD Alliance

F. L. Pagán

Cognitive Disorders

ZINCARE

M. Mataa

MDS 2024 Insights: Eye Movement Disorders in Parkinsonian Syndromes

Diego Kaski

Approach to Cognitive Impairment in Adults

ZINCARE

M. Mataa

Gut Microbiome and the Brain

BRAIN PONDERINGS podcast with Mark Mattson

J. Cryan

Early Diagnosis of Alzheimer’s Disease

Sharon Cohen

New & Emerging Treatments in Alzheimer's Disease

University of Miami

E. Crocco

AAIC 2024 Insights: Effects of Gut Microbiota Dysbiosis on Cognitive…

AAIC 2024 Insights Hub

Y. (Laura) Zhang

Updates in Dementia

2023 Conference Coverage

P. Tipton

Detection of Cutaneous Phosphorylated Alpha-Synuclein for Diagnosis …

University of Utah Neurology

C. Gibbons

AAIC 2024 Insights: Potential of Targeting the Alpha-1 Adrenergic Re…

AAIC 2024 Insights Hub

S. G. Pattanashetty

Alzheimer's: Clinical Pearls

Lawrence Robbins

AAIC 2024 Insights: Developing an AI Algorithm to Detect Predictors …

AAIC 2024 Insights Hub

J. Butler

Deep Brain Stimulation for Parkinson's Disease: A Surgeon's Perspect…

University of Iowa Movement Disorders Center

J. Greenlee

The Illusion of Progress: Lecanemab in Alzheimer's Disease

Alberto Espay

Unpacking Parkinsonism: Understanding Movement Changes in LBD

Lewy Body Dementia Association

J. Fleisher

AAIC 2024 Insights: qEEG as Biomarker for Alzheimer's Disease - Inve…

AAIC 2024 Insights Hub

C. Simfukwe